Dermapharm Holding SE

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 1 159
EBIT TTM (mln): 219
index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 391 385 444 467 572 701 794 943 1,025 1,135 1,181
Przychód Δ r/r 0.0% -1.7% 15.5% 5.1% 22.5% 22.4% 13.3% 18.8% 8.7% 10.8% 4.0%
Marża brutto 43.7% 46.7% 45.2% 47.4% 52.4% 54.7% 58.4% 65.8% 64.5% 63.3% 65.0%
EBIT (mln) 43 61 87 92 108 120 137 298 244 183 217
EBIT Δ r/r 0.0% 40.5% 42.8% 6.1% 16.7% 11.2% 14.5% 118.1% -18.4% -24.9% 18.6%
EBIT (%) 11.1% 15.8% 19.5% 19.7% 18.8% 17.1% 17.2% 31.7% 23.8% 16.1% 18.4%
Koszty finansowe (mln) 10 11 9 7 6 10 9 9 12 55 58
EBITDA (mln) 75 95 106 112 140 170 191 348 329 266 321
EBITDA(%) 19.2% 24.6% 23.8% 23.9% 24.5% 24.2% 24.0% 36.9% 32.1% 23.4% 27.2%
Podatek (mln) 2 3 6 10 29 32 39 84 84 45 60
Zysk Netto (mln) -0 13 17 78 75 77 86 210 134 62 114
Zysk netto Δ r/r 0.0% -20921.3% 32.5% 362.1% -3.1% 2.5% 11.2% 144.2% -36.0% -53.5% 82.4%
Zysk netto (%) -0.0% 3.3% 3.8% 16.6% 13.2% 11.0% 10.8% 22.2% 13.1% 5.5% 9.6%
EPS -0.0011 0.24 1.54 1.56 1.41 1.43 1.59 3.89 2.49 1.16 2.11
EPS (rozwodnione) -0.0011 0.24 1.43 1.56 1.41 1.43 1.59 3.89 2.49 1.16 2.11
Ilośc akcji (mln) 54 54 50 50 53 54 54 54 54 54 54
Ważona ilośc akcji (mln) 54 54 54 54 53 54 54 54 54 54 54
Waluta EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR